ProteoGenix SAS is a French antibody production company founded in 2003, providing integrated solutions for custom antibody development, recombinant protein expression, and bioproduction services. The company offers therapeutic antibody discovery, humanization using proprietary AI, ADC development, bispecific antibody development, CAR-T platforms, and custom cell line development across 6 manufacturing sites. ProteoGenix serves the therapeutics, diagnostics, research, and animal health markets.
custom antibody development and production, AI-powered antibody humanization, ADC and bispecific antibody development, recombinant protein expression, cell line development
1 site worldwide
Involvement in 1 clinical trial
No certifications on file yet.
No reviews available yet.
No documents available.